Cardiotoxicity and Risk Factors in Patients With Colorectal Cancer Receiving Fluoropyrimidine

ABSTRACT: observational prospective study, designed for patients with colorectal cancer receiving for the first time 5-FU or capecitabine, with or without other chemotherapy combinations.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Cardiotoxicity

PROVIDER: 2206955 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR